Pharmacy Procurement & Supplier Qualification
A practical B2B framework for evaluating insulin pen needle suppliers through exact-SKU control, compatibility evidence, documentation, landed cost, lot traceability, U.S. replenishment and postmarket support.
Scope: This article is an educational procurement resource for pharmacies, clinics, distributors and healthcare purchasing teams. It does not recommend a pen needle for an individual, establish compatibility for a specific pen, provide legal advice or replace current product labeling, prescribing requirements, organizational policy or applicable law. Product identity, compatibility, documentation, inventory and commercial terms must be confirmed for the exact quoted REF.
Quick answer
What Makes an Insulin Pen Needle Supplier Reliable?
A reliable supplier can connect every quotation to an exact, reviewable pen needle SKU: legal manufacturer, trade name, REF, gauge × length, standard or safety design, compatibility evidence, current label and IFU, applicable U.S. product records, UDI/GTIN where applicable, pack hierarchy, lot and expiration controls, inventory source and change-notification process.
Price and warehouse location matter only after these identity and compatibility gates are passed. A pharmacy should approve the complete SKU and supply program—not a generic claim such as “universal,” “FDA certified,” “100-count pen needles” or “U.S. stock.” Buyers can review current wholesale insulin pen needle options, then request a REF-specific documentation and availability review.
Executive summary
Key Takeaways for Pharmacy Buyers
- Choose the supply model that fits the demand. U.S. inventory, factory-direct supply, distributor consolidation and hybrid replenishment solve different problems.
- Define the approved SKU before comparing suppliers. Gauge, length, hub, standard/safety design, sterile presentation, REF and pack level belong in the purchasing specification.
- Compatibility is a controlled claim. Physical attachment alone is not enough; require current evidence that identifies both the quoted needle and intended pen or a clearly defined interface scope.
- Registration is not product clearance. FDA states that registration and listing do not denote approval, clearance or authorization.[4]
- Compare total landed cost per accepted box. Include freight, handling, import cost where applicable, inspection, short-dated inventory and shortage exposure.
- Qualify the operating process. Samples, first-order receiving, lot traceability, complaints, recalls and change control reveal whether the supply program works after the quotation is signed.
1. Start with the Pharmacy’s Supply Model
“Manufacturer or distributor?” is not a universal either-or decision. The correct source depends on order size, SKU count, required delivery window, private-label scope, document depth and the cost of a shortage. A local distributor may be the better source for small, mixed replenishment orders; a factory-direct route may fit stable annual demand or custom packaging; a hybrid program can cover immediate requirements while longer production replenishes upstream stock.
| Supply model | Best-fit requirement | Potential advantage | Buyer verification |
|---|---|---|---|
| U.S. inventory / domestic fulfillment | Routine or urgent standard-SKU replenishment | Shorter domestic delivery path | REF-level on-hand quantity, lot, expiration, allocation and replenishment source |
| Factory direct | Predictable volume, planned buys or OEM | Specification and packaging flexibility | MOQ, production lead time, importer roles, quality scope and logistics responsibility |
| Medical distributor | Mixed brands, products or low case quantities | Consolidated ordering and established account service | Authorized source, traceability, return terms, document access and shortage allocation |
| Hybrid program | Near-term stock plus longer-term cost planning | Balances speed and upstream continuity | Whether domestic and factory routes supply the same REF, label, pack and records |
Do not award points for “factory direct” or “U.S. warehouse” as slogans. Ask what exact operational problem the model solves, who owns each inventory position, and what happens when the primary route is constrained. Tonmit’s U.S. warehouse-supported replenishment framework correctly treats availability as SKU-, lot-, quantity- and cycle-specific rather than permanent universal stock.
2. Define the Exact Pen Needle SKU Before Comparing Suppliers
A description such as “32G 4 mm pen needles, 100 count” is not yet a purchase specification. It omits the interface, design type, manufacturer identity, REF, label revision and package hierarchy. Two products with the same gauge and length can differ in hub geometry, cartridge-end needle, shield mechanism, tip design, sterile barrier, barcode level and compatibility scope.
Gauge and length should always be written together, but neither proves compatibility. The 4 mm–8 mm pen needle sizes and compatibility guide explains the technical fields in detail. Keep that size-focused content on the specialist guide; use the present article to decide whether a supplier can repeatedly deliver the already approved configuration.
Recommended purchase-order control: No substitution of manufacturer, labeler, REF, gauge, length, interface, standard/safety design, sterile presentation, packaging or label revision without documented buyer approval.
3. Apply Five Pass-or-Fail Supplier Requirements
A weighted score should never compensate for a fundamental identity or safety gap. Screen every insulin pen needle supplier through non-negotiable gates before comparing price, service or private-label capability.
| Gate | Pass requirement | Pause or reject when |
|---|---|---|
| 1. Product identity | Legal manufacturer, labeler, site, trade name and exact REF are disclosed | The seller withholds the manufacturer or quotes only a generic description |
| 2. Compatibility | Current evidence covers the quoted REF and intended pen/interface scope | “Universal” is the only support or the evidence identifies another model |
| 3. U.S. documentation | Product records, current label/IFU and quality documents reconcile to the SKU | An unofficial “FDA certificate” is offered instead of traceable product evidence |
| 4. Traceability | Lot, expiration, packaging version and recall contacts can be controlled | The supplier cannot connect shipped lots to purchase and customer records |
| 5. Change control | Manufacturer, design, site, label, packaging and compatibility changes require notice | The supplier may substitute any “equivalent” item during shortages |
Only suppliers that pass all five gates should move to the commercial scorecard. An attractive price, a sample that physically screws onto a pen or a quality-system certificate cannot repair an unresolved mismatch in product identity.
4. Verify Manufacturer, Product and Regulatory Identity
In the United States, a pen needle is not qualified by a supplier’s company profile alone. The buyer needs a traceable product-identity chain. The eCFR classifies the hypodermic single-lumen needle under 21 CFR 880.5570 as Class II.[1] ISO 11608-2:2022 specifies requirements and test methods for single-use, double-ended, sterile pen needles used with certain non-integrated needle-based injection systems.[2]
Quoted item → legal manufacturer → trade name → exact REF → gauge × length → standard/safety design
Exact REF → applicable clearance/listing → UDI/GTIN where applicable → current label/IFU → package hierarchy
Received product → lot and expiration → receiving record → storage location → outbound order or dispensing record
FDA explicitly states that it does not issue registration certificates to medical-device facilities and that registration and listing do not denote approval, clearance or authorization.[4] Therefore, ask which product code, 510(k), listing and label apply to the exact model—not simply whether the supplier is “FDA registered.” A public 510(k), such as K161950, can help verify a named device family and listed models, but it should not be stretched to cover every gauge, 5-bevel, “Plus,” safety or private-label configuration sold by a company.[3]
FDA’s UDI system is intended to identify devices from manufacturing through distribution and patient use. The device identifier identifies the labeler and specific version or model; production information can include lot, expiration or manufacturing date when those data appear on the label.[5] Request a product-specific documentation package that reconciles these records with the offered artwork and REF.
5. Validate Insulin Pen Needle Compatibility
Compatibility is often reduced to “fits most pens,” but physical attachment alone is not a complete test. The cartridge-end needle must access the medication path as designed; the hub must attach and detach correctly; the intended dose-setting and delivery workflow must follow the pen instructions; and the claim must apply to the quoted commercial REF.
| Compatibility field | Evidence to capture | Approval question |
|---|---|---|
| Pen injector | Manufacturer, marketed name, model/presentation and current instructions | Is this the pen used by the pharmacy program? |
| Pen needle | Manufacturer, brand, REF, gauge, length, hub and design type | Does the evidence identify the same item quoted? |
| Compatibility source | Current needle label/IFU, controlled matrix or supported interface statement | Is the scope explicit and revision-controlled? |
| Use limits | Named restrictions, included accessories and single-use directions | Are any target pens or workflows excluded? |
| Change control | Revision date and notification terms for hub, label or compatibility changes | Will the approved combination return to review when it changes? |
Do not infer that every GLP-1 pen accepts an attachable needle. Some current presentations have integrated needles, while other products or presentations follow different device pathways. The guide to which GLP-1 presentations use separate pen needles should be consulted before accessory demand is assigned.
6. Separate Standard and Safety Pen Needle Requirements
A standard pen needle and a safety pen needle are not interchangeable purchasing descriptions. Safety products add a feature intended to reduce accidental sharps exposure, but mechanisms differ. The buyer should review activation, patient-end coverage, lockout, visibility, removal and disposal for the exact device.
| Use environment | Procurement emphasis | Required review |
|---|---|---|
| Retail dispensing for self-use | Approved standard SKU, compatibility, pack count and supply continuity | Current label/IFU, prescription or program requirements and single-use education |
| Employee-administered injections | Safety-engineered device evaluation where occupational exposure applies | Exposure-control plan, frontline employee input, device evaluation and training |
| Mixed pharmacy/clinic program | Separate product masters for standard and safety designs | Prevent picking, contracting and substitution errors between the two types |
OSHA requires covered employers with occupational exposure to maintain an exposure-control plan and document consideration and implementation of appropriate commercially available and effective safer medical devices; it also calls for input from non-managerial employees responsible for direct patient care in device evaluation.[7] This does not mean that every retail box must be a safety design. It means professional-use requirements should be assessed through the employer’s actual exposure-control process.
7. Review Packaging, Barcodes, Lot Control and Shelf Life
For pharmacy operations, a correct needle inside an unsuitable package can still fail. Buyers need a pack hierarchy that fits inventory, dispensing and traceability systems. “100 count” identifies only one level and does not state boxes per case, case barcode, pallet quantity or remaining shelf life.
- Individual sterile-barrier format and visible package-damage criteria.
- Units per box, boxes per case, units per case and cases per pallet.
- Box and case dimensions, gross weight and barcode location.
- REF, GTIN/UDI where applicable, label revision and country of origin.
- Lot, manufacture date and expiration format on each applicable level.
- Labeled shelf life and minimum remaining shelf life at shipment and receipt.
- Storage and transport conditions supported by the exact label—not assumed cold chain.
- Process for damaged, short-dated, quarantined, returned or recalled stock.
Run a desktop traceability exercise before full approval: select a hypothetical lot, locate every inventory position, identify affected outbound orders, demonstrate quarantine and name the person responsible for customer communication. A barcode is useful only when the records behind it support action.
8. Compare Total Landed Cost—not Only Box Price
Supplier quotations become comparable only after the exact SKU, pack hierarchy, shelf-life requirement and delivery basis are normalized. A lower unit price may be offset by freight, customs and importer costs, high MOQ, short-dated write-off, receiving discrepancies or shortage-related emergency buying.
Landed cost per box = product + freight + customs/import cost + handling + inspection + financing + expected write-off
Landed cost per accepted needle = total landed order cost ÷ needles meeting approved SKU, pack, shelf-life and receiving criteria
Risk-adjusted comparison = accepted-unit cost + expected shortage, obsolescence, return and quality-event cost
| Quote field | Supplier A | Supplier B | Normalization rule |
|---|---|---|---|
| Exact REF and configuration | [enter] | [enter] | Do not compare different designs as equivalent |
| Units/box and boxes/case | [enter] | [enter] | Calculate needles per case |
| Price and Incoterm | [enter] | [enter] | Include all costs to the same destination |
| MOQ and payment terms | [enter] | [enter] | Include working-capital impact |
| Remaining shelf life | [enter] | [enter] | Apply the same minimum acceptance threshold |
| Lead time and fill commitment | [enter] | [enter] | Separate current stock from replenishment lead time |
9. Verify U.S. Inventory and Replenishment Capability
“U.S. warehouse” should trigger a set of questions, not an automatic high score. Inventory can be physically domestic but unavailable, allocated, short-dated, held under another REF or unsupported by a reliable upstream replenishment plan.
- Request usable on-hand quantity by exact REF, lot and expiration date.
- Separate available, allocated, quarantined, damaged and inbound quantities.
- Confirm the warehouse location, order cutoff, carrier service and destination ZIP.
- Record current domestic delivery time separately from factory replenishment time.
- Ask how frequently stock is reconciled and when inventory evidence was generated.
- Define backorder allocation, shortage notice, partial-shipment and alternate-SKU rules.
- For recurring demand, agree on forecast sharing, safety stock or reserved inventory terms.
Tonmit’s current supply pages describe U.S. warehouse support as an availability review rather than a guarantee that every pen needle remains stocked. That is the correct procurement framing: confirm the exact REF and transaction each time, then measure fill rate and delivery performance over repeated orders.
10. Evaluate Complaints, Recalls and Change Control
Supplier qualification does not end at delivery. The pharmacy needs an identified route for complaints, nonconforming goods, reportable-event escalation, field actions, recalls, returns and product changes. The response process should include the legal manufacturer and other responsible parties—not stop with a sales representative.
| Process | Buyer question | Evidence to retain |
|---|---|---|
| Complaint intake | Who receives urgent and routine complaints, and within what time? | Named contacts, escalation levels and acknowledgment targets |
| Investigation / CAPA | How are samples, lots, root cause and corrective action handled? | Procedure, sample report and closure-time expectation |
| Recall / field action | Can affected lots, inventory and customers be identified rapidly? | Recall procedure and traceability exercise result |
| Change notification | Which design, site, material, sterilization, label or pack changes require notice? | Written notice period and requalification triggers |
| Shortage substitution | Can another SKU be shipped without approval? | Written prohibition and authorized alternate list |
FDA’s Medical Device Recall database and MAUDE database can support background review, but neither should be interpreted without matching the correct manufacturer, brand, model, event context and reporting limitations.[8][9] A database search is an input to supplier review—not a standalone pass/fail verdict.
11. Run a Sample and First-Order Qualification
A sample review can confirm appearance, labeling and basic handling, but it does not prove routine production consistency or long-term supply performance. Use samples to close specific questions, then treat the first commercial order as a controlled qualification lot.
| Stage | Required check | Release decision |
|---|---|---|
| Document review | REF, label, IFU, compatibility, regulatory mapping and quality files agree | Approve, request clarification or reject |
| Sample review | Packaging, markings, hub, shields and approved compatibility evaluation | Record sample lot and reviewer; do not approve by appearance alone |
| PO control | Exact SKU, pack, shelf life, delivery basis and no-substitution clause | Release PO only after exceptions are resolved |
| Receiving | PO-to-REF match, count, lot, expiration, barcode, label revision and condition | Accept, quarantine or reject under documented criteria |
| Post-receipt | System scanning, put-away, traceability and issue escalation work as designed | Approve routine ordering or require corrective action |
For private-label projects, complete product identity, labeler responsibility, artwork control, UDI/GUDID responsibility where applicable, complaint exchange and change management before commercial artwork approval. Tonmit’s private-label and OEM medical supply program provides a starting point for these project-specific discussions.
12. Use a 100-Point Supplier Scorecard
After the five mandatory gates are passed, use a weighted score to compare qualified candidates. Adjust the weights to the pharmacy’s actual risk, but publish the scoring definitions before quotations are reviewed.
| Category | Weight | What a high score requires |
|---|---|---|
| Product identity & compatibility | 20 | Exact-REF records, current compatibility evidence and controlled substitutions |
| Documentation & quality support | 20 | Connected, current files; responsive clarification; relevant QMS scope |
| Inventory & supply continuity | 20 | Verified stock, realistic replenishment, allocation rules and shortage communication |
| Total landed cost & terms | 15 | Comparable quotation, transparent freight/terms and manageable MOQ |
| Packaging & system fit | 10 | Correct pack hierarchy, barcode levels, shelf life and receiving compatibility |
| Complaints, recalls & change control | 10 | Named owners, traceability, response targets and advance notice |
| Sample & first-order execution | 5 | Accurate documents, product, shipping and receiving performance |
| Total | 100 | Apply only after all pass/fail gates are satisfied |
After onboarding, replace promises with performance data: OTIF, fill rate, minimum-shelf-life compliance, order and document accuracy, complaint acknowledgment time, investigation closure time, unauthorized substitution count and change-notice lead time.
13. Supplier Red Flags Pharmacies Should Avoid
Pause the evaluation when a supplier:
- provides only an “FDA certificate” and cannot map the exact REF to current product records;
- claims every pen needle is “FDA approved,” “FDA certified,” universally compatible or guaranteed painless;
- uses one 510(k) to support every gauge, tip design, safety structure or private-label SKU;
- will not disclose the legal manufacturer, labeler, manufacturing site or REF;
- quotes a box price without units/case, Incoterm, freight basis, shelf life or destination;
- describes U.S. stock without REF-level usable quantity, lot and expiration evidence;
- reserves the right to ship an “equivalent” manufacturer or specification during shortages;
- cannot demonstrate complaint, recall, traceability and change-notification processes;
- describes normal storage as cold chain without support from the exact product label.
FDA’s QMSR became effective February 2, 2026 and incorporates ISO 13485:2016 by reference within the amended 21 CFR Part 820 framework.[6] A current ISO 13485 certificate can support quality-system review, but it does not replace SKU identity, compatibility, labeling, U.S. market records or the supplier’s operating performance.
14. Copyable Insulin Pen Needle RFQ Template
Send the same complete requirement to every candidate and ask suppliers to disclose exceptions line by line. This prevents a low quotation for a non-equivalent product from leading the comparison.
Buyer and program: [pharmacy / clinic / distributor]; target market [country/state]; intended supply environment [retail dispensing / employee administration / other].
Required product: sterile, single-use [standard / safety] insulin pen needle.
Needle specification: [32G × 4 mm / 31G × 5 mm / 31G × 6 mm / 31G × 8 mm / other]; disclose tip, wall or safety claims that form part of the quotation.
Compatibility: intended pen manufacturer/model(s) [list]; provide current label, IFU or controlled compatibility evidence covering the exact quoted REF.
Product identity: legal manufacturer, manufacturing site, trade name, labeler/brand, exact REF, UDI/GTIN where applicable and current label revision.
U.S. documentation: product code/class, applicable 510(k) and model mapping, current registration/listing information as applicable, label/IFU, quality-system scope and requested technical/quality files.
Packaging: individual sterile barrier, units/box, boxes/case, units/case, cases/pallet, box/case dimensions and weight, barcode at each level, lot and expiration format.
Shelf life: labeled shelf life [months/years]; minimum remaining shelf life at shipment and receipt [months].
Demand: initial quantity [boxes/cases]; monthly requirement [units]; annual forecast [units]; mixed-size requirement [yes/no].
Commercial terms: MOQ, sample cost, unit/box/case price, Incoterm, payment terms, production lead time, destination ZIP [ZIP] and required delivery date.
Inventory route: current U.S. usable stock by REF/lot/expiration or factory production route; upstream replenishment time; backorder allocation and shortage-notice process.
Private label: [standard packaging / custom box / OEM]; artwork, MOQ, tooling/setup, labeler/UDI responsibilities, validation and change-control requirements.
Postmarket support: complaint, nonconformance, return, recall and urgent escalation contacts with response targets.
Substitution: no change to manufacturer, labeler, REF, gauge, length, interface, design, sterile package, label or case hierarchy without written buyer approval.
For a wider multi-category order, buyers can also source a broader diabetes care supply program after each product family has its own approved SKU and documentation path.
Buyer FAQ: Choosing an Insulin Pen Needle Supplier
Are all insulin pen needles universal?
No blanket “universal” claim should be accepted without controlled evidence. Verify the exact pen model or defined interface, exact pen needle REF, current label/IFU or compatibility matrix, restrictions and revision date.
Will a 32G × 4 mm pen needle fit every insulin pen?
Gauge and length describe needle dimensions; they do not prove interface compatibility. Approval requires evidence for the specific 32G × 4 mm REF and intended pen or defined compatible interface scope.
What documents should an insulin pen needle supplier provide?
Request legal manufacturer and labeler identity, exact REF, current label/IFU, applicable 510(k) and model mapping, registration/listing and UDI/GUDID information where applicable, compatibility evidence, quality-system scope, sterile-barrier and shelf-life support, packaging hierarchy, traceability and change-control documents.
Is FDA establishment registration enough to qualify a pen needle?
No. FDA states that registration and listing do not denote approval, clearance or authorization, and FDA does not issue registration certificates to medical-device facilities. Verify the exact device and applicable product records.
What is the difference between standard and safety pen needles?
A safety pen needle includes a feature intended to reduce accidental sharps exposure; activation and coverage mechanisms vary. Standard and safety designs require separate SKU, workflow, training, cost and occupational-exposure review.
Do all GLP-1 pens require separate pen needles?
No. Requirements depend on the exact medication presentation and device. Some presentations accept attachable needles; others use integrated needles or vial-and-syringe pathways. Review current labeling before planning accessories.
Are insulin pen needles single-use?
Pen needles covered by ISO 11608-2 are single-use devices, and current device instructions should control use. The supply forecast should plan a new compatible needle for each injection event rather than assuming reuse. See the single-use and supply-planning guide.
How many pen needles are packed per box and case?
Box and case quantities are REF- and supply-path-specific. A 100-count box does not establish boxes per case. Require units/box, boxes/case, total units/case, pallet quantity, dimensions, weight and barcode levels on the quotation and PO.
What remaining shelf life should a pharmacy require?
Set a documented minimum based on forecast, distribution time, downstream requirements and inventory turnover. Compare suppliers against the same threshold and confirm remaining shelf life by lot before shipment and again at receiving.
Can different pen needle sizes be mixed in one wholesale order?
This depends on the supplier, MOQ and fulfillment route. If mixed sizes are permitted, keep each REF, case quantity, label, compatibility status and price separate; mixed ordering does not make the SKUs interchangeable.
Can a supplier substitute another pen needle during a shortage?
Not without documented buyer approval. The alternate must pass identity, compatibility, design, packaging, documentation and organizational-review requirements before shipment.
What should pharmacies compare besides price?
Compare exact-SKU identity, compatibility, documentation quality, usable inventory, replenishment performance, shelf life, pack hierarchy, traceability, complaint/recall support, change control, payment terms and total landed cost.
Can a pharmacy request samples before a bulk order?
Many B2B programs can review samples by request, but sample availability and cost vary. Record the sample REF and lot, define the evaluation, and confirm that the approved commercial order will use the same controlled specification.
What does a private-label pen needle project add to the review?
Private label can add labeler identity, artwork, UDI/GUDID, device listing, complaint, recall, validation and change-control responsibilities. Resolve these roles before artwork approval and commercial production.
Conclusion: Approve the Complete SKU and Supply Program
The best insulin pen needle supplier is not simply the company with the lowest 100-count box price, the broadest “universal” claim or a warehouse in the United States. It is the supplier that can repeatedly deliver the approved REF, prove the relevant compatibility scope, connect product and regulatory identity, maintain lot and expiration traceability, meet shelf-life and replenishment requirements, and notify the buyer before material changes or substitutions.
For pharmacies, the practical workflow is clear: choose the right supply model, freeze the exact SKU, apply five pass/fail gates, normalize landed cost, qualify the first order and score ongoing performance. This turns supplier selection from a marketing comparison into a controlled, auditable purchasing decision.
SKU · compatibility · documentation · replenishment
Request a Pen Needle Supplier Review
Share the required gauge × length, intended pen models, standard or safety design, packaging, annual volume, destination ZIP code, minimum shelf life, documentation list and private-label requirements. Tonmit can review selected TonmiCare product paths, exact-SKU documentation, current availability and wholesale terms.
Final manufacturer, REF, compatibility, regulatory mapping, packaging, inventory, shelf life, delivery and private-label feasibility are confirmed for the selected product and transaction.
References
- Electronic Code of Federal Regulations. “21 CFR 880.5570—Hypodermic single lumen needle.” Defines the device and classifies it as Class II. eCFR.
- International Organization for Standardization. “ISO 11608-2:2022—Needle-based injection systems for medical use—Part 2: Double-ended pen needles.” Covers requirements and test methods for single-use, double-ended, sterile needles used with certain non-integrated needle-based injection systems. ISO.
- U.S. Food and Drug Administration. “K161950—Verifine Common Type Insulin Pen Needle and Verifine Safety Type Insulin Pen Needle.” Public clearance and summary identifying specific models within the submitted families. FDA 510(k) record.
- U.S. Food and Drug Administration. “Important Reminders about Registration and Listing.” FDA does not issue registration certificates, and registration/listing do not denote approval, clearance or authorization. FDA.
- U.S. Food and Drug Administration. “UDI Basics.” Describes device identifiers, production identifiers and GUDID submission responsibilities. FDA.
- U.S. Food and Drug Administration. “Quality Management System Regulation (QMSR).” The QMSR became effective February 2, 2026 and incorporates ISO 13485:2016 by reference. FDA.
- Occupational Safety and Health Administration. “29 CFR 1910.1030—Bloodborne Pathogens.” Includes exposure-control planning and consideration of safer medical devices for covered occupational-exposure settings. OSHA.
- U.S. Food and Drug Administration. “Medical Device Recalls.” Searchable recall database with posting and classification context. FDA.
- U.S. Food and Drug Administration. “Manufacturer and User Facility Device Experience (MAUDE) Database.” Searchable medical device report database with stated reporting and search limitations. FDA.
